AXT INC (AXTI) Stock Fundamental Analysis
USA - NASDAQ:AXTI - US00246W1036 - Common Stock
6.19 USD
+0.13 (+2.15%)
6.08 USD
-0.11 (-1.78%)
Overall AXTI gets a fundamental rating of 1 out of 10. We evaluated AXTI against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI has a bad profitability rating. Also its financial health evaluation is rather negative. AXTI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year AXTI has reported negative net income.
In the past year AXTI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
In multiple years AXTI reported negative operating cash flow during the last 5 years.
1.2 Ratios
AXTI has a worse Return On Assets (-7.30%) than 69.64% of its industry peers.
The Return On Equity of AXTI (-13.36%) is worse than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.3% | ||
| ROE | -13.36% | ||
| ROIC | N/A |
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of AXTI (11.94%) is worse than 86.61% of its industry peers.
In the last couple of years the Gross Margin of AXTI has declined.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.94% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
2. Health
2.1 Basic Checks
AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
AXTI has more shares outstanding than it did 1 year ago.
AXTI has more shares outstanding than it did 5 years ago.
AXTI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.10, we must say that AXTI is in the distress zone and has some risk of bankruptcy.
AXTI's Altman-Z score of 1.10 is on the low side compared to the rest of the industry. AXTI is outperformed by 73.21% of its industry peers.
AXTI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, AXTI is doing worse than 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.1 |
ROIC/WACCN/A
WACC11.27%
2.3 Liquidity
AXTI has a Current Ratio of 1.82. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AXTI (1.82) is worse than 76.79% of its industry peers.
A Quick Ratio of 0.82 indicates that AXTI may have some problems paying its short term obligations.
AXTI's Quick ratio of 0.82 is on the low side compared to the rest of the industry. AXTI is outperformed by 90.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The earnings per share for AXTI have decreased strongly by -59.38% in the last year.
The Revenue has decreased by -2.64% in the past year.
Measured over the past years, AXTI shows a small growth in Revenue. The Revenue has been growing by 3.59% on average per year.
EPS 1Y (TTM)-59.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-35.63%
3.2 Future
Based on estimates for the next years, AXTI will show a decrease in Earnings Per Share. The EPS will decrease by -5.84% on average per year.
The Revenue is expected to grow by 2.06% on average over the next years.
EPS Next Y-137.15%
EPS Next 2Y-5.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.41%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AXTI. In the last year negative earnings were reported.
Also next year AXTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AXTI's earnings are expected to decrease with -5.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
AXTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.19
+0.13 (+2.15%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners34.39%
Inst Owner Change0.02%
Ins Owners2.43%
Ins Owner Change4.11%
Market Cap285.48M
Revenue(TTM)86.08M
Net Income(TTM)-24008000
Analysts83.64
Price Target3.9 (-37%)
Short Float %2.75%
Short Ratio0.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.81%
Min EPS beat(2)-42.91%
Max EPS beat(2)-14.71%
EPS beat(4)1
Avg EPS beat(4)-38.98%
Min EPS beat(4)-130.68%
Max EPS beat(4)32.39%
EPS beat(8)4
Avg EPS beat(8)-8.56%
EPS beat(12)8
Avg EPS beat(12)4.8%
EPS beat(16)11
Avg EPS beat(16)7.87%
Revenue beat(2)0
Avg Revenue beat(2)-5.46%
Min Revenue beat(2)-10.9%
Max Revenue beat(2)-0.03%
Revenue beat(4)1
Avg Revenue beat(4)-4.72%
Min Revenue beat(4)-10.9%
Max Revenue beat(4)2.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.41%
Revenue beat(12)4
Avg Revenue beat(12)-2.44%
Revenue beat(16)5
Avg Revenue beat(16)-2.03%
PT rev (1m)0%
PT rev (3m)-3.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.59 | ||
| P/tB | 1.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.87
BVpS3.9
TBVpS3.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.3% | ||
| ROE | -13.36% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.94% | ||
| FCFM | N/A |
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.03% | ||
| Cap/Sales | 2.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.1 |
F-Score3
WACC11.27%
ROIC/WACCN/A
Cap/Depr(3y)178.33%
Cap/Depr(5y)282.49%
Cap/Sales(3y)13.27%
Cap/Sales(5y)16.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-137.15%
EPS Next 2Y-5.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-35.63%
Revenue Next Year-19.41%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-81.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.6%
OCF growth 3YN/A
OCF growth 5YN/A
AXT INC / AXTI FAQ
What is the fundamental rating for AXTI stock?
ChartMill assigns a fundamental rating of 1 / 10 to AXTI.
What is the valuation status of AXT INC (AXTI) stock?
ChartMill assigns a valuation rating of 0 / 10 to AXT INC (AXTI). This can be considered as Overvalued.
Can you provide the profitability details for AXT INC?
AXT INC (AXTI) has a profitability rating of 1 / 10.
What is the financial health of AXT INC (AXTI) stock?
The financial health rating of AXT INC (AXTI) is 1 / 10.